Ledger.Open graph →
SEC Form D · filed August 6, 2021

Unravel Biosciences, Inc

Offering
$1.0M
Sold
$500K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Richard Novak · Boston, MAExec · DirectorDonald Ingber · Boston, MADirectorFrederic Vigneault · Boston, MAExec · DirectorLewis Geffen · Boston, MAExecRichard Novak · Boston, MAExec · DirectorDonald Ingber · Boston, MADirectorFrederic Vigneault · Boston, MAExec · DirectorLewis Geffen · BOSTON, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗